NASDAQ:DFFN
Delisted
Diffusion Pharmaceuticals Inc Stock Company Profile
$5.87
+0 (+0%)
At Close: Nov 28, 2023
Information
300 East Main Street, Suite 201
Charlottesville VA 22902
434 220 0718
www.diffusionpharma.com
Industry: Biotechnology
Sector: Healthcare
Description
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.
